Welcome to the House Committee on Energy and Commerce

WASHINGTON, D.C. – Today, Congressman Brett Guthrie (KY-02), Chairman of the House Committee on Energy and Commerce, Congressman John Joyce, M.D. (PA-13), Chairman of the Subcommittee on Oversight and Investigations, and Congressman Gary Palmer (AL-06), Chairman of the Subcommittee on Environment, sent a letter to Environmental Protection Agency (EPA) Administrator Lee Zeldin requesting information on how far-left organizations received billions of dollars in the final days of the previous administration through the Greenhouse Gas Reduction Fund (GGRF).  “In the final days of the Biden-Harris Administration, the EPA put their far-left allies ahead of the American people, giving away Greenhouse Gas Reduction Fund grants worth nearly $30 billion to recipients who were not equipped to receive such large amounts of funding,” said Chairmen Guthrie, Joyce, and Palmer. “By requesting documentation about this grant process from the EPA, Republicans on the Committee on Energy and Commerce are continuing our work to root out waste, fraud, and abuse while being good stewards of taxpayer dollars.”  This letter follows requests sent to eight nonprofits who were awarded more than $20 billion earlier this year through the GGRF. Key excerpt from the letter: “The Committee finds the potential for financial mismanagement particularly worrisome, as some of the grantees’ previous revenues were only a small fraction of the GGRF funds they received, which raises questions about whether the grant recipients can adequately manage grant amounts that are significantly larger than their previously documented revenue.” “The Committee seeks to ensure that the federal government is a good steward of taxpayer dollars and to continue supporting EPA’s efforts in combatting waste, fraud, and abuse within the GGRF program. To assist with the Subcommittee’s investigation of GGRF and support the Administration’s efforts, the Committee requests the following documents no later than November 19, 2025: The complete grant file for the three NCIF grantees and the five CCIA grantees, including the application submitted by the organization with all supporting documentation and appendices, any additional information requested by EPA, and any memos on changes to the grant terms and conditions. The scoring breakdown and rational for each score for all the NCIF and CCIA applicants included in the final rankings lists for the top-ranked applications, including any changes to scoring or rescores and rationale for why those changes occurred. Any checklist or guidance for EPA grants employees on what steps they should be taking to conduct appropriate pre-award due diligence and to ensure all required paperwork and documentation is submitted and verified. This should include briefing materials used to advise the Administrator, Deputy Administrator, Chief of Staff, General Counsel, Associate Administrator for Mission Support, and Associate Administrator for the Office of Air and Radiation about the selection of NCIF grantees and CCIA grantees. Any reports received from Citibank or the U.S. Treasury regarding the account balances or transactions histories of the GGRF accounts for the three NCIF grantees and the five CCIA grantees and any of their sub-awardees. Any progress reports received from the three NCIF grantees and the five CCIA grantees. The names of all panel chairs, senior review panels, selection officials, and all individuals involved in the review panels for all the NCIF and CCIA applicants included in the final rankings lists for the top-ranked applications.” Background: The Inflation Reduction Act (IRA) authorized the Environmental Protection Agency (EPA) to create and implement a $27 billion GGRF program. Of this appropriation, $20 billion was awarded to just eight grant recipients; with $14 billion awarded to three grant recipients under the National Clean Investment Fund (NCIF) program and $6 billion awarded to five grant recipients under the Clean Communities Investment Accelerator (CCIA) program.  CLICK HERE to read the full letter. Read More About this Ongoing Investigation: “SCOOP: Biden-era grant program described as ‘gold bar’ scheme by Trump EPA administrator under scrutiny” –   Fox News “EXCLUSIVE: Key Committee Demands Docs in Biden ‘Gold Bars’ Probe” – Daily Caller ###

WASHINGTON, D.C. – In case you missed it, Breitbart recently featured Congressman Brett Guthrie (KY-02), Chairman of the House Committee on Energy and Commerce, and Congressman Morgan Griffith (VA-09), Chairman of the Subcommittee on Health, who shared ways in which Republicans have already voted to lower health care premiums that Democrats opposed in the Working Families Tax Cuts. In Case You Missed It: “House Energy and Commerce Committee Chairman Brett Guthrie (R-KY) and Health Subcommittee Chairman Rep. Morgan Griffith (R-VA) told Breitbart News that Republican proposals would have lowered health insurance premiums by nearly double compared to the Biden-era enhanced Obamacare credits. “What we’ve heard from both sides of the aisle is that Obamacare is not affordable. But what we’ve not heard is Democrats acknowledge the waste, fraud, and abuse that’s been enabled by these temporary subsidies — including massive handouts to big health insurance companies and expanded taxpayer subsidies to the wealthiest Obamacare enrollees,’ Guthrie told Breitbart News in a written statement. “Congressional Democrats’ demands to open the government are partly based on the premise that affordable health care is out of reach for many Americans. What Democrats now want as part of $1.5 trillion in additional federal spending is a permanent and everlasting program that they designated to expire in 2025,’ Griffith told Breitbart News. “The congressmen spoke to Breitbart News as the Democrat shutdown has continued for more than a month. Democrats shut down the government over expiring Biden-era enhanced Affordable Care Act (ACA), or Obamacare, credits. Democrats first enhanced the Obamacare credits through the Biden coronavirus stimulus plan, the $1.9 trillion American Rescue Plan. The Democrat party then continued the credits with the passage of the so-called Inflation Reduction Act until the end of 2025, where Guthrie says they spent most of the month refusing to work with Republicans on meaningful solutions to lower healthcare costs. “With the Democrat-designed sunset date of December 31 for these COVID-era subsidies, we could have been utilizing this month to continue finding more tangible, meaningful solutions to make health care more affordable for Americans. Instead, Democrats chose to hold the American people hostage over billion-dollar handouts to big insurance companies,’ the Energy and Commerce Committee chairman continued. “Democrats initially created the temporary COVID-19 era ‘enhanced’ premium tax credits to help people who struggled from the economic fallout of the pandemic. But now, Democrats are doubling down on the temporary ‘enhanced’ credits as a means to subsidize Obamacare,’ Griffith said. “He added, ‘Whether intended or not, this is a stunning admission that President Obama’s signature healthcare program, Obamacare, has failed to provide affordable health care to the American people. Issues to soften the impacts of the Democratic Party’s failed policies can be discussed if we get the government open again.’ “Republicans such as Guthrie have criticized the Obamacare enhanced credits, more formally known as the Enhanced Premium Tax Credit (EPTC), because they are essentially direct payments to health insurers to lower healthcare costs. “While Democrats such as House Minority Leader Hakeem Jeffries have accused Republicans of not wanting to provide health care to ‘everyday Americans,’ Democrats moved to nix substantial reform that would have drastically lowered health insurance premiums while the Big Beautiful Bill worked its way through the Senate. “In June, Democrats lobbied the Senate parliamentarian to scrap the ACA cost-sharing reduction payments (CSRs) from the Big Beautiful Bill, saying that it violates the Byrd Rule and thus requires 60 votes to be included in Trump’s Big Beautiful Bill. Funding CSRs would lower benchmark silver premiums used to set subsidy amounts. CSR payments are a type of financial assistance that would help lower out-of-pocket costs for eligible individuals and families that enroll in a Silver Obamacare plan. “The Congressional Budget Office (CBO) found that these healthcare reforms would have lowered healthcare premiums by 12.7 percent and reduced costs by decreasing the need for Obamacare EPTCs CSR. CSR would have lowered costs by $30.8 billion. “Andy Slavitt, President Barack Obama’s Centers for Medicare & Medicaid Services (CMS) administrator, in 2017 said that CSR payments would drastically reduce health insurance premiums: “Democrats have not once approached me, or my staff, to find a path forward. Republicans, time and again, have voted for policies that lower healthcare premiums by nearly double what extending Democrats’ temporary COVID Credits would. Democrats unanimously opposed these commonsense policies and actively worked to undermine our efforts to lower premiums for the 7 percent of Americans who choose to enroll in an Obamacare plan. We stand ready to work across the aisle to advance real solutions that address the root causes impacting health care affordability,’ Guthrie continued. “The Biden-era enhanced Obamacare credits were meant to alleviate the costs of the pandemic and will soon expire. The generous nature of the subsidies gave some of the wealthiest Americans access to these benefits. This includes, according to the Energy and Commerce Committee: In North Carolina, an early retiree worth over $10 million qualified for over $17,000 in annual taxpayer subsidies for his Obamacare plan. Accountants in Texas were actively advertising how they were helping multi-millionaires get free or nearly free health insurance based on Democrats’ temporary COVID Credits. A family of four in Arizona making $600,000 a year, a married couple in West Virginia making $580,000, a single person in Vermont making $180,000 a year… taxpayers were suddenly subsidizing these people’s Obamacare plans thanks to the Democrats’ temporary COVID Credit policy. “The Paragon Health Institute estimated that annual Obamacare enrollment fraud could exceed $26 billion. The same think tank also found that the expiring Obamacare credits minimally impacted 2026 premiums, which counters a Democrat narrative that the expiration of those credits is responsible for health insurance price increases.” ###

WASHINGTON, D.C.  – Congressman Brett Guthrie (KY-02), Chairman of the House Committee on Energy and Commerce, announced the Committee’s new Chief Counsel of the Subcommittee on Communications and Technology is Michael Essington. Subcommittee on Communications and Technology Chief Counsel—Michael Essington Michael Essington will serve as Chief Counsel for the Subcommittee on Communications and Technology. Most recently, Michael led efforts at the EchoStar Corporation to engage Capitol Hill Republicans and the Trump Administration as Senior Manager of Government Affairs. Michael previously served on Capitol Hill for over eight years in the House and Senate, including as General Counsel for Senator Todd Young where he focused on commerce, telecom, and media issues. Before moving to Washington, Michael worked in the private sector at an Am Law 100 firm in Chicago and served over six years in the U.S. Marine Corps Reserve. Michael is a graduate of the Chicago-Kent College of Law and received bachelor’s degrees in philosophy and accounting from Cedarville University. ###

WASHINGTON, D.C.  – Congressman Brett Guthrie (KY-02), Chairman of the House Committee on Energy and Commerce, Congressman Gus Bilirakis (FL-12), Chairman of the Subcommittee on Commerce, Manufacturing, and Trade, and Congressman John Joyce, M.D. (PA-13), Chairman of the Subcommittee on Oversight and Investigations, sent letters to Pam Bondi, U.S. Attorney General, Andrew Ferguson, Chairman of the Federal Trade Commission, and Howard Lutnick, Secretary of the U.S. Department of Commerce, urging the administration to investigate and address potential national security risks posed by BrainCo, a neural technology company allegedly funded by the People’s Republic of China (PRC). KEY EXCERPTS: “The Committee on Energy and Commerce has long warned about the national and economic security risks of CCP-aligned entities accessing Americans’ personal and proprietary information. The use of American data by CCP-aligned entities, such as BrainCo, to develop and deploy AI underscores our concerns. […] The Committee urges swift action to investigate and address the potential national and economic security risks posed by BrainCo’s operations in the United States and its access to Americans’ personal information.” BACKGROUND: According to recent reporting , the company was started by MIT and Harvard scientists but has “been quietly backed by the Chinese government-linked entities for nearly a decade.”  BrainCo products reportedly harvest personalized brainwave data from users.  BrainCo is reportedly working with sanctioned PRC military contractors.  BrainCo products reportedly have been used by Olympic gold medalist Mikaela Shiffrin, number two world tennis player, Jannik Sinner, U.S. Olympic teams, and many others.  Along with DeepSeek , BrainCo is considered one of China’s “Six Little Dragons” — meaning one of the CCP’s most promising young tech startups. The PRC’s National Intelligence Law of 2017 requires PRC individuals and entities to support PRC intelligence services. CLICK HERE to read exclusive coverage of the letter. CLICK HERE to read the Hunterbrook Media story on their investigation into BrainCo. CLICK HERE to listen to the corresponding Pablo Torre Finds Out podcast episode. CLICK HERE to read the letters to Attorney General Bondi, Chairman Ferguson, and Secretary Lutnick. ###

WASHINGTON, D.C.  – In case you missed it, the Washington Examiner published an article featuring a letter from House Committee on Energy and Commerce Chairman Brett Guthrie (KY-02) and Ranking Member Frank Pallone Jr. (NJ-06), along with Energy and Commerce Subcommittee on Oversight and Investigations Chairman John Joyce, M.D. (PA-13), and Ranking Member Yvette D. Clarke (NY-09), requesting a briefing on HRSA’s ongoing oversight of patient safety in the nation’s organ procurement and transplant system. In Case You Missed It: “House Republicans and Democrats are pressing the Department of Health and Human Services to increase transparency on possible ‘systemic problems’ and ‘threats to patient safety’ in the national organ transplant system, according to a letter obtained by the Washington Examiner. “Bipartisan leadership on the Energy and Commerce Committee wrote to Health Resources and Services Administrator Thomas Engels on Friday, probing whether the agency is able to conduct a wide-ranging review of patient safety after multiple reported incidents of organ donor patients being egregiously mistreated by organ procurement organizations. “Chairman Brett Guthrie (R-KY), along with ranking Democratic Rep. Frank Pallone (NJ), John Joyce (R-PA), and Yvette Clarke (D-NY), said in a joint statement on Tuesday that their investigation into the organ procurement system ‘has demonstrated the need for further oversight’ and that problems may exist nationwide. “The American people should be able to have full faith and confidence in our organ donor and transplant system, and we will continue to work together to prevent these harmful practices from continuing,’ said the bipartisan representatives in their statement. “The Energy and Commerce Committee began its longer-term investigation testimony last fall about a Kentucky patient, Anthony Thomas Hoover II, whose family agreed to proceed with organ donation following an overdose in 2021. “Although Hoover’s neurological condition improved, representatives from the Kentucky Organ Donor Affiliates, the organ procurement organization serving Kentucky, moved forward with the organ retrieval process. Records indicate that Hoover woke up on the operating table before the retrieval surgery, and hospital staff intervened to stop the procedure. “HRSA, which oversees the national Organ Procurement and Transplantation Network and its contractor organ procurement organizations, conducted its own internal investigation into the Kentucky situation following the revelation of Hoover’s case. “The HRSA corrective action plan, issued in May, examined 351 organ procurement cases in Kentucky between December 2024 and February 2025 that did not result in donation. “About 30% of those cases, 103 patients, presented ‘concerning features,’ including 73 patients who showed neurological signs of life after being approved for organ donation surgery and 28 patients who may have survived entirely since there was no cardiac time of death recorded. “Other ‘concerning features’ of the incidents in the HRSA report, according to Guthrie and his House colleagues, include ‘issues related to patient and family interactions, medical assessments and healthcare team interactions, recognition of high neurological function, and recognition and documentation of drugs in patient records.’ “HRSA’s testimony and other public reports suggest that these patterns are not limited to instances detailed in HRSA’s report and may exist in other parts of the country,’ Guthrie and his colleagues wrote. “The bipartisan representatives in their letter cited a New York Times piece published in August about Misty Hawkins, 42, from Alabama, who was taken off life support in the spring of 2024 and prepped for organ donation. Doctors discovered while she was on the operating table that her heart was still beating and she was breathing during her organ retrieval surgery. “Last week, another story came to light of a 22-year-old patient from Kentucky who, in 2019, was taken to surgery to have his organs removed for donation despite still having a heartbeat and not being declared brain dead. “Larry Black Jr., who arrived at the hospital a week prior due to a gunshot wound to the head, was rescued from surgery just in time by another physician. Now at 28, he is a father to three children. “HHS Secretary Robert F. Kennedy Jr. directed HRSA in July to conduct a deeper investigation into the Kentucky organ procurement case, saying that ‘the entire system must be fixed to ensure that every potential donor’s life is treated with the sanctity it deserves.’ “But the agency has not yet announced plans for a nationwide review of organ transplant systems. “Guthrie and his House colleagues requested that HRSA provide more information on the current status of all patient safety complaints that the agency has received and whether or not HRSA has the capacity ‘to initiate other wide-ranging reviews appropriate, in response to a patient safety complaint that may suggest a systemic problem.’ “The committee requested a staff-level briefing no later than September 26. “Americans’ confidence in the system comes when patient safety is protected,’ said the bipartisan House coalition.”   ###

WASHINGTON, D.C.  – House Committee on Energy and Commerce Chairman Brett Guthrie (KY-02) and Ranking Member Frank Pallone Jr., (NJ-06), along with Energy and Commerce Subcommittee on Oversight and Investigations Chairman John Joyce, MD (PA-13), and Ranking Member Yvette D. Clarke (NY-09), wrote to the Health Resources and Services Administration (HRSA) requesting a briefing on its ongoing oversight of patient safety in our nation’s organ procurement and transplant system.   In July, the Committee’s Oversight and Investigations Subcommittee held a hearing in response to a HRSA investigative report that found patient safety concerns at Kentucky Organ Donor Affiliates (KYDA) – the organ procurement organization (OPO) serving the state of Kentucky. In the investigative report, HRSA revealed that of the 351 cases reviewed, 103 cases (29.3 percent) showed “concerning features.” These concerning features included problems with patient-family interactions, medical assessments and team interactions, recognition of high neurologic function, and recognition and documentation of drugs in records.   In addition, HRSA issued a corrective action plan to address the findings in its report specific to KYDA and directing the Organ Procurement and Transplantation Network (OPTN) Board of Directors to develop certain safety guidelines for the entire OPTN. The corrective action plan raised further questions about the possibility that there may be more systemic issues at OPOs across the country, noting that “ [s]ince the review of KYDA was initiated, HRSA has received reports of similar patterns of high risk [donation after circulatory death] procurement practices at other OPOs .” Moreover, during the July hearing, HRSA’s Organ Transplant Branch Chief, Dr. Raymond Lynch was questioned about the potential failure to adhere to existing protocols by Rep. Erin Houchin (IN-09): “ is it a broader systemic issue or is it limited to KYDA ?” Dr. Lynch responded that “ [u]nfortunately, it is not limited to KYDA. During the course of this investigation we received concerns that were in areas served by other OPOs. ”  Chairmen Guthrie and Joyce and Ranking Members Pallone and Clarke issued the following joint statement:    “ The Committee’s examination of the organ procurement and transplant system has demonstrated the need for further oversight.  Testimony from the July hearing, HRSA’s investigative report and corrective action plan, and continued reports of similar patterns at other OPOs all raise serious concerns. The American people should be able to have full faith and confidence in our organ donor and transplant system, and we will continue to work together to prevent these harmful practices from continuing. Americans’ confidence in the system comes when patient safety is protected. ”    Read the full letter  here . Background:  ·       During the 118th Congress, the Committee on Energy and Commerce  passed  the Securing the U.S. Organ Procurement and Transplantation Network Act to both modernize the OPTN and allow HRSA to institute a competitive contracting process to find the best contractors for various OPTN functions. This legislation was signed into law on September 22, 2023.   ·       On March 20, 2024, the Committee  launched an investigation  into the organ procurement and transplantation system by sending  a letter  to United Network for Organ Sharing (UNOS) requesting information related to concerns surrounding data security and operability, patient safety and equity, and conflicts of interest.    ·       On March 20, 2024, the Committee also sent  a letter  to HRSA requesting information related to implementation of the Securing the U.S. Organ Procurement and Transplantation Network Act as well as other concerns related to effective oversight and management.   ·       On September 11, 2024, the Subcommittee on Oversight and Investigations held a  hearing  that focused on the implementation of reforms at the OPTN, including the need for stronger oversight and accountability as well as ongoing patient safety concerns.   ·       During the hearing, questions were raised related to allegations of mismanagement and patient safety concerns after patients began exhibiting signs of increased neurologic function after being previously deemed suitable as an organ donation candidate. Several of these allegations, particularly those related to patient safety, were later substantiated through the findings contained in HRSA’s March 2025 report.   ·       On March 24, 2025, HRSA’s Division of Transplantation issued a  report  that summarized the findings of its investigation into KYDA, the OPO now known as Network for Hope, which serves Kentucky and parts of Ohio, West Virgina, and Indiana.  ·       On May 28, 2025, HRSA issued a  CAP  to OPTN, which directed the OTPN to take specific actions within a specified period of time, including developing a 12-month OPTN monitoring plan for KYDA to address concerns identified. The corrective action plan also requires the OPTN to propose policies for public comment to improve safeguards for potential donation after circulatory death (DCD) patients in the organ procurement process and increase information shared with patient families regarding DCD organ procurement.   ·       On July 22, 2025, the House Committee on Energy and Commerce’s Subcommittee on Oversight and Investigations held a  hearing  examining concerning practices within our nation’s organ procurement and transplant system that were identified by HRSA’s investigation.   ###